Management of acute ischemic stroke
F Herpich, F Rincon - Critical care medicine, 2020 - journals.lww.com
Objectives: Concise “synthetic” review of the state of the art of management of acute
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …
Ischaemic stroke
Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
E Berge, W Whiteley, H Audebert… - European stroke …, 2021 - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …
Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection
Background Thrombolytic agents, including tenecteplase, are generally used within 4.5
hours after the onset of stroke symptoms. Information on whether tenecteplase confers …
hours after the onset of stroke symptoms. Information on whether tenecteplase confers …
Management of acute ischemic stroke
MS Phipps, CA Cronin - Bmj, 2020 - bmj.com
Stroke is the leading cause of long term disability in developed countries and one of the top
causes of mortality worldwide. The past decade has seen substantial advances in the …
causes of mortality worldwide. The past decade has seen substantial advances in the …
Thrombolysis for acute ischaemic stroke: current status and future perspectives
Alteplase is currently the only approved thrombolytic agent for treatment of acute ischaemic
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …
stroke, but interest is burgeoning in the development of new thrombolytic agents for systemic …
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
Executive summary Stroke is the second leading cause of death worldwide. The burden of
disability after a stroke is also large, and is increasing at a faster pace in low-income and …
disability after a stroke is also large, and is increasing at a faster pace in low-income and …
Advances in acute ischemic stroke therapy
Y Xiong, AK Wakhloo, M Fisher - Circulation research, 2022 - Am Heart Assoc
The treatment of acute ischemic stroke continues to advance. The mainstay of treatment
remains intravenous thrombolysis with alteplase. Recent studies demonstrated that later …
remains intravenous thrombolysis with alteplase. Recent studies demonstrated that later …
Update on treatment of acute ischemic stroke
AA Rabinstein - Continuum: Lifelong Learning in Neurology, 2020 - journals.lww.com
Abstract EDITOR'S NOTE The article “Update on Treatment of Acute Ischemic Stroke” by Dr
Rabinstein was first published in the February 2017 Cerebrovascular Disease issue of …
Rabinstein was first published in the February 2017 Cerebrovascular Disease issue of …
The potential impact of neuroimaging and translational research on the clinical management of lacunar stroke
S Rudilosso, A Rodríguez-Vázquez, X Urra… - International journal of …, 2022 - mdpi.com
Lacunar infarcts represent one of the most frequent subtypes of ischemic strokes and may
represent the first recognizable manifestation of a progressive disease of the small …
represent the first recognizable manifestation of a progressive disease of the small …